Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
To determine the long-term safety and tolerability of SR121463B in patients with syndrome of
inappropriate antidiuretic secretion (SIADH). To assess the long-term efficacy of SR121463B
in maintaining normal levels of serum sodium in patients with SIADH.
Long term safety is evaluated further in an open label extension study with flexible doses of
satavaptan.